Events in our system are self-managed.  Group and event managers are encouraged to review privacy and security settings, and adjust them if needed.  If you need assistance please contact Indico Support - contact Help at bottom of page. https://learn.getindico.io/categories/managing/

19–24 Oct 2025
Chateau Fairmont Whistler
America/Vancouver timezone

Molecular Selectivity in a FEBIAD: Inversion of Isobaric Ratios Through Operational Parameter Optimization

21 Oct 2025, 19:32
1m
MacDonald Foyer (Fairmont Chateau Whistler)

MacDonald Foyer

Fairmont Chateau Whistler

Poster contribution Isotope production, target, and ion source techniques Poster Session

Speaker

Fernando Alejandro Maldonado Millan (TRIUMF)

Description

Molecular ion production from the TRIUMF FEBIAD ion source was systematically studied as a function of source operating parameters. During an opportunistic beamtime shift, the FEBIAD was optimized while isobaric species were measured using TITAN’s MR-TOF mass spectrometer. Exploring parameter "islands" revealed how each region corresponds to distinct molecular species. This approach was particularly relevant with CF₄ injection into an unirradiated UCx target, where molecular fragments such as 19F and CF3 were mapped in the FEBIAD operational space. UF+, the molecule of interest, and WOF₃+, the dominant isobaric contaminant, were studied, with optimization resulting in an inversion of their ratio. This allowed for a cleaner UF+ signal while maintaining the same overall rate. Initially, the ratio of the target molecule to the isobaric contaminant was 4% which could be increased to 97% by selecting optimal FEBIAD operating parameters, highlighting the critical importance of careful FEBIAD operation parameter selection, as well as the need to have a diagnostic that allows to separate target molecules from isobaric contamination.

Email address maldonado@triumf.ca
Classification Isotope production, target, and ion source techniques

Primary author

Co-authors

Presentation materials

There are no materials yet.